Trial Profile
A phase 1 study to assess pharmacokinetics,safety and tolerability of Glecaprevir and Pibrentasvir coadministered with calcium channel blockers Felodipine or Amlodipine in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Apr 2017
Price :
$35
*
At a glance
- Drugs Glecaprevir (Primary) ; Pibrentasvir (Primary) ; Amlodipine; Felodipine
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 08 Apr 2017 New trial record
- 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics